Details for Patent: 9,597,409
✉ Email this page to a colleague
Which drugs does patent 9,597,409 protect, and when does it expire?
Patent 9,597,409 protects ABRAXANE and is included in one NDA.
Protection for ABRAXANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-five patent family members in twenty-three countries.
Summary for Patent: 9,597,409
| Title: | Methods of treating cancer |
| Abstract: | The present invention provides methods and compositions for treating non-small-cell lung cancer (NSCLC) by administering a) a composition comprising nanoparticles that comprise paclitaxel and an albumin and b) a platinum-based agent (e.g., carboplatin). The present application also provides methods of treating prostate cancer by administering to the individual a) an effective amount of a composition comprising nanoparticles comprising docetaxel and an albumin; and b) an effective amount of a steroid. |
| Inventor(s): | Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA) |
| Assignee: | ABRAXIS BIOSCIENCE, LLC (Los Angeles, CA) |
| Application Number: | 13/782,990 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,597,409 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
More… ↓ |
Drugs Protected by US Patent 9,597,409
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-myers | ABRAXANE | paclitaxel | POWDER;INTRAVENOUS | 021660-001 | Jan 7, 2005 | AB | RX | Yes | Yes | 9,597,409*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,597,409
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011235344 | ⤷ Subscribe | |||
| Australia | 2016202000 | ⤷ Subscribe | |||
| Brazil | 112012024442 | ⤷ Subscribe | |||
| Canada | 2793974 | ⤷ Subscribe | |||
| Canada | 3087813 | ⤷ Subscribe | |||
| China | 103118665 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
